Petros Pharmaceuticals (PTPI) Stock Chart & Stock Price History → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free PTPI Stock Alerts $0.68 0.00 (-0.15%) (As of 12:33 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Petros Pharmaceuticals Stock Price Performance5 Day Performance-4.11%1 Month Performance-26.55%3 Month Performance-42.03%6 Month Performance-49.33%Year-To-Date Performance-51.49%1 Year Performance-82.99% Receive PTPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. PTPI Stock Chart for Wednesday, May, 8, 2024 PTPI Chart by TradingView Petros Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.69$0.69-1.01%$0.70$0.6880,576 shs$4.71 million05/06/2024$0.71$0.69-2.99%$0.72$0.68140,135 shs$4.76 million05/03/2024$0.68$0.71+5.36%$0.77$0.69373,689 shs$4.91 million05/02/2024$0.66$0.68+3.04%$0.71$0.67117,556 shs$4.66 million05/01/2024$0.66$0.66+0.08%$0.68$0.64142,751 shs$4.52 million04/30/2024$0.70$0.66-6.76%$0.70$0.64120,693 shs$4.52 million Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.64$0.70+10.03%$0.71$0.65155,404 shs$4.84 million04/26/2024$0.64$0.64$0.66$0.6377,209 shs$4.40 million04/25/2024$0.63$0.64+0.87%$0.65$0.60217,698 shs$4.40 million04/24/2024$0.68$0.63-6.72%$0.69$0.62184,764 shs$4.37 million04/23/2024$0.65$0.68+4.60%$0.71$0.64613,565 shs$4.68 million04/22/2024$0.67$0.65-2.97%$0.69$0.63201,094 shs$4.47 million04/19/2024$0.70$0.68-2.91%$0.70$0.67161,629 shs$4.66 million04/18/2024$0.69$0.70+1.14%$0.73$0.65230,520 shs$4.80 million04/17/2024$0.71$0.69-2.13%$0.73$0.64457,077 shs$4.74 million04/16/2024$0.78$0.71-9.97%$0.90$0.661.94 million shs$4.85 million04/15/2024$0.83$0.78-6.09%$0.82$0.74542,781 shs$5.39 million04/12/2024$0.91$0.83-8.36%$0.91$0.83346,125 shs$1.84 million04/11/2024$0.89$0.91+2.76%$0.94$0.84348,695 shs$2.00 million04/10/2024$0.91$0.89-2.79%$0.91$0.81375,946 shs$1.95 million04/09/2024$0.93$0.91-2.18%$0.94$0.89199,052 shs$2.00 million04/08/2024$0.93$0.93+0.67%$0.95$0.88388,043 shs$2.05 million04/05/2024$0.95$0.93-2.62%$0.95$0.92239,389 shs$2.04 million04/04/2024$0.93$0.95+2.15%$1.00$0.91421,152 shs$2.09 million04/03/2024$1.07$0.93-13.08%$1.03$0.901.31 million shs$2.05 million04/02/2024$1.40$1.07-23.57%$1.22$1.012.00 million shs$2.35 million04/01/2024$1.48$1.40-5.41%$1.48$1.39314,589 shs$3.08 million03/29/2024$1.48$1.48$1.52$1.42378,806 shs$3.26 million03/28/2024$1.45$1.48+2.07%$1.52$1.42367,507 shs$3.26 million03/27/2024$1.55$1.45-6.45%$1.52$1.39754,292 shs$3.19 million03/26/2024$1.57$1.55-1.27%$1.58$1.48729,235 shs$3.41 million03/25/2024$1.50$1.57+4.67%$1.59$1.46557,993 shs$3.45 million03/22/2024$1.50$1.50$1.55$1.44633,185 shs$3.30 million03/21/2024$1.41$1.50+6.38%$1.54$1.36762,038 shs$3.30 million03/20/2024$1.45$1.41-2.76%$1.43$1.34938,675 shs$3.10 million03/19/2024$1.47$1.45-1.36%$1.67$1.415.10 million shs$3.19 million03/18/2024$1.52$1.47-3.29%$1.60$1.45321,533 shs$3.23 million03/15/2024$1.38$1.52+10.14%$1.58$1.40814,211 shs$3.34 million03/14/2024$1.44$1.38-3.83%$1.41$1.30537,491 shs$3.04 million03/13/2024$1.49$1.44-3.69%$1.50$1.42442,466 shs$3.16 millionTech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.03/12/2024$1.56$1.49-4.49%$1.56$1.47769,256 shs$3.28 million03/11/2024$1.63$1.56-4.29%$1.65$1.56499,647 shs$3.43 million03/08/2024$1.50$1.63+8.67%$1.65$1.52762,912 shs$3.59 million03/07/2024$1.60$1.50-6.25%$1.60$1.50353,188 shs$3.30 million03/06/2024$1.51$1.60+5.96%$1.63$1.47784,914 shs$3.52 million03/05/2024$1.63$1.51-7.36%$1.61$1.46965,625 shs$3.32 million03/04/2024$1.67$1.63-2.40%$1.66$1.56547,851 shs$3.59 million03/01/2024$1.72$1.67-2.91%$1.75$1.62653,623 shs$3.67 million02/29/2024$1.68$1.72+2.38%$1.75$1.64843,162 shs$3.79 million02/28/2024$1.66$1.68+1.20%$1.76$1.601.62 million shs$3.70 million02/27/2024$1.58$1.66+5.06%$1.70$1.581.06 million shs$3.65 million02/26/2024$1.65$1.58-4.24%$1.67$1.49974,322 shs$3.48 million02/23/2024$1.66$1.65-0.60%$1.69$1.58661,928 shs$3.63 million02/22/2024$1.59$1.66+4.40%$1.70$1.57943,713 shs$3.65 million02/21/2024$1.56$1.59+1.92%$1.68$1.52807,310 shs$3.50 million02/20/2024$1.50$1.56+4.00%$1.58$1.52419,818 shs$3.43 million02/19/2024$1.50$1.50$1.58$1.43497,100 shs$3.30 million02/16/2024$1.54$1.50-2.60%$1.58$1.43479,507 shs$3.30 million02/15/2024$1.60$1.54-3.75%$1.59$1.40728,830 shs$3.39 million02/14/2024$1.54$1.60+3.90%$2.27$1.324.74 million shs$3.52 million02/13/2024$1.40$1.54+10.00%$1.61$1.313.08 million shs$3.39 million02/12/2024$1.17$1.40+19.66%$1.43$1.201.48 million shs$3.08 million02/09/2024$1.18$1.17-0.85%$1.20$1.12156,312 shs$2.57 million02/08/2024$1.13$1.18+4.42%$1.20$1.09228,442 shs$2.60 million02/07/2024$1.14$1.13-0.88%$1.17$1.11151,163 shs$2.49 million Related Companies: China Pharma Stock Chart Lipella Pharmaceuticals Stock Chart Exicure Stock Chart Artelo Biosciences Stock Chart NexImmune Stock Chart Bright Minds Biosciences Stock Chart Oragenics Stock Chart Cingulate Stock Chart Ensysce Biosciences Stock Chart Genprex Stock Chart Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTPI) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.